Comparison between the breast preserving surgery and the ordinary breast surgery on breast oncoplastic surgeries in National Cancer Institute\ Misurata- Libya
Abstract
Objective: to determine the breast cancer recurrence rate, complications, and aesthetic outcome of breast oncoplastic surgery among patients managed in National Cancer Institute\Misurata-Libya (NCI) that they underwent breast oncoplastic surgery(BOS) also to analyze the results between two patients groups underwent breast reconstruction with Lattissimus Dorsi(LD) flap in 1st group and Transverse Rectus Abdominus Myocutaneous(TRAM) flap in 2nd group.
Methods: Retrospective study of 56 patients in oncological surgery department In the NCI between 1st January 2014 to 30th December 2018, have been included. In the study period, a total of 56 cases of breast cancer underwent BOS. 11 patient underwent modified radical mastectomy (MRM) with LDMF reconstruction and 17 case underwent modified radical mastectomy(MRM) with TRAM flap, 26 case underwent breast preserving surgery(BPS), 2 cases presented with phyllodes tumor and managed by subcutaneous mastectomy and implant reconstruction. Early results show acceptable cosmetic results of these cases.
Results: The most occurred complications in both groups (LD&TRAM ) are wound infection, hematoma & partial flap necrosis. In conclusion, we find that LD flap is a safe and low-morbidity technique with a relatively low complication rate.
Conclusion: Oncoplastic breast surgery combines the principles of surgical oncology with those of plastic and reconstructive surgery and our initial experience shows that BOS leads to aesthetically pleasing and oncological sound results.
References
2. Sarkar D, Maji A, Saha S, Biswas JK. Oncoplastic breast surgerye our experiences in the breast Clinic, IPGME&R, Kolkata.Indian J Surg Oncol. 2011;2:112e117.
3. Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: a classification of quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol.2010;17:1375e1391.
4. Rancati A, Gonzalez E, Dorr J, Angrigiani C. Oncoplastic surgery in the treatment of breast cancer. Ecancermedicalscience.2013;7:293.
5. Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol. 2000;55:219e232.
6. Al-Ghazal SK, Fallowfield L, Blamey RW. Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. Eur J Surg Oncol. 1999;25:344e346.
7. Thorne CH, editor. Grabb and Smith’s Plastic Surgery. 6thed. Lippincott Williams & Wilkins; 2007 Hammond DC. Latissimus dorsi flap breast reconstruction. In:. p. 634e40.
8. Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol 2015;22:361.
9. Russell RC, Pribaz J, Zook EG, Leighton WD, Eriksson E, Smith CJ.Functional evaluation of latissimus dorsi donor site. Plast Reconstr Surg1986;78:336.
10. Schneider WJ, Hill HL Jr, Brown RG. Latissimus dorsi myocutaneous flap for breast reconstruction. Br J Plast Surg 1977;30:277.
11. D’Aniello C, Grimaldi L, Barbato A, Bosi B, Carli A. Cosmetic results in 242 patients treated by conservative surgery for breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1999;33:419e422.
12. Down SK, Jha PK, Burger A, Hussien MI. Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer. Breast J. 2013;19:56e63.
13. Fitoussi AD, Berry MG, Fama` F, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases. Plastic Reconstr Surg. 2010;125:454e462.
